Monitoring Protocols for Cochlear Toxicity
暂无分享,去创建一个
[1] Lisa L. Hunter,et al. Evaluation of Speed and Accuracy of Next-Generation Auditory Steady State Response and Auditory Brainstem Response Audiometry in Children With Normal Hearing and Hearing Loss , 2018, Ear and hearing.
[2] K. Knight,et al. Ototoxicity monitoring in children treated with platinum chemotherapy , 2018, International journal of audiology.
[3] C. McEvoy,et al. Monitoring neonates for ototoxicity , 2018, International journal of audiology.
[4] D. Konrad-Martin,et al. Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions , 2018, International journal of audiology.
[5] D. Konrad-Martin,et al. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology , 2018, International journal of audiology.
[6] Tanisha L. Hammill,et al. Protection for medication-induced hearing loss: the state of the science , 2018, International journal of audiology.
[7] V. Manchaiah,et al. Ototoxicity: A Challenge in Diagnosis and Treatment , 2018, Journal of audiology & otology.
[8] A. Boothroyd,et al. High-Frequency Distortion-Product Otoacoustic Emission Repeatability in a Patient Population , 2017, Ear and hearing.
[9] G. McMillan,et al. Long-Term Variability of Distortion-Product Otoacoustic Emissions in Infants and Children and Its Relation to Pediatric Ototoxicity Monitoring , 2017, Ear and hearing.
[10] B. Gál,et al. Genetic risk factors of cisplatin induced ototoxicity in adult patients. , 2016, Neoplasma.
[11] W. Dreschler,et al. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: A systematic review of the literature , 2015, Head & neck.
[12] Shaum P. Bhagat,et al. Challenges in ototoxicity monitoring in the pediatric oncology population. , 2014, Journal of the American Academy of Audiology.
[13] G. McMillan,et al. Proposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA). , 2014, Journal of rehabilitation research and development.
[14] P. Steyger,et al. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] S. Fausti,et al. Ototoxicity Monitoring: Program Approaches and Considerations , 2011 .
[16] Frederick J. Gallun,et al. Distortion-Product Otoacoustic Emission Test Performance for Ototoxicity Monitoring , 2010, Ear and hearing.
[17] A. Grimes,et al. American Academy of Audiology Position Statement , 2010 .
[18] S. Fausti,et al. Factors Affecting Sensitivity of Distortion-Product Otoacoustic Emissions to Ototoxic Hearing Loss , 2008, Ear and hearing.
[19] K. Knight,et al. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] S. Fausti,et al. Audiological Monitoring of Patients Receiving Ototoxic Drugs , 2005 .
[21] S. Fausti,et al. Hearing health and care: the need for improved hearing loss prevention and hearing conservation practices. , 2005, Journal of rehabilitation research and development.
[22] N. Fischel‐Ghodsian. Genetic Factors in Aminoglycoside Toxicity , 1999, Pharmacogenomics.
[23] Alison M. Bobal,et al. Comparison of ABR stimuli for the early detection of ototoxicity: conventional clicks compared with high frequency clicks and single frequency tonebursts. , 2003, Journal of the American Academy of Audiology.
[24] R. Santarelli,et al. Global Problem of Drug‐Induced Hearing Loss , 1999, Annals of the New York Academy of Sciences.
[25] M P Gorga,et al. Comparison between intensity and pressure as measures of sound level in the ear canal. , 1998, The Journal of the Acoustical Society of America.
[26] S. Neely,et al. From Laboratory to Clinic: A Large Scale Study of Distortion Product Otoacoustic Emissions in Ears with Normal Hearing and Ears with Hearing Loss , 1997, Ear and hearing.
[27] R H Wilson,et al. High‐Frequency Audiometric Monitoring Strategies for Early Detection of Ototoxicity , 1994, Ear and hearing.
[28] J. Durrant,et al. Audiologic monitoring for ototoxicity. , 1993, Otolaryngologic clinics of North America.
[29] J. Johnson,et al. Hearing loss--risk factor for cisplatin ototoxicity? Observations. , 1990, The American journal of otology.
[30] G. Studebaker,et al. Placement of vibrator in bone-conduction testing. , 1962, Journal of speech and hearing research.